title: Intravitreal triamcinolone in cystoid macular edema due to uveitis and repeated surgery after a penetrating trauma.
abstract: OBJECTIVE
  To test the effectiveness of intravitreal triamcinolone acetonide in treating macular edema due to multiple vitreoretinal surgical procedures and uveitis after a penetrating trauma with metallic foreign body retention in a 37-year-old man.
  
  
  METHODS
  The patient received two intravitreal injections of triamcinolone acetonide-2 mg/0.05 mL and 4 mg/0.1 ml(-1) month apart. The 6-month follow-up included best-corrected visual acuity (BCVA) measurement and optical coherence tomography evaluation.
  
  
  RESULTS
  After the first injection (2 mg) the foveal thickness (685 microm, as compared to a normal value of <165 microm) and the BCVA (20/200) remained unchanged with respect to the preinjection values; 1 week after the second injection (4 mg), the foveal thickness went down to 130 microm and the BCVA improved (20/80). Such results were unchanged at the 6-month control. No complications occurred.
  
  
  CONCLUSIONS
  A 2 mg dose of triamcinolone acetonide did not improve the anatomic and functional status of the macula. A 4 mg dose markedly improved BCVA and reduced the macular thickness in this case of macular edema.
authors.affiliation: Department of Ophthalmology, Ospedale Civile dello Spirito Santo, Pescara - Italy. ro.perilli@tiscali.it
authors.forename: M
authors.initials: M
authors.lastname: Marullo
authors.forename: R
authors.initials: R
authors.lastname: Perilli
authors.forename: E
authors.initials: E
authors.lastname: Balestrazzi
mesh_terms: D000328:Adult; D005129:Eye Foreign Bodies / Q000150:complications* / Q000601:surgery; D015807:Eye Injuries, Penetrating / Q000150:complications* / Q000601:surgery; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D019654:Lens Implantation, Intraocular; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D018918:Phacoemulsification; D012086:Reoperation; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014605:Uveitis / Q000150:complications*; D014821:Vitrectomy; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide